Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-10-20
2011-11-29
Marvich, Maria (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S023100, C536S024100, C536S024500
Reexamination Certificate
active
08067384
ABSTRACT:
The present invention provides a prophylactic, ameliorative or therapeutic medicament for vascular restenosis, ischemic disease, allergic disease, inflammatory disease, autoimmune disease, or cancer metastasis, invasion (cancer metastasis/invasion) or cachexia based on the inhibitory action on a plural of transcriptional regulatory factor. A chimera (double) decoy of the present invention has plural transcriptional regulatory factor binding sequences in a single molecule thereof. Thus, it is able to inhibit the activity of plural transcriptional regulatory factors with a single molecule. For example, stenosis of an anastomosed site of an artificial blood vessel is caused by thickening of the vascular intima, and this is mainly caused by activation of cell proliferation by an inflammatory reaction occurring at the anastomosed site. Thus, thickening of vessel walls can be inhibited by simultaneously inhibiting two transcriptional regulatory factors involved in inflammation and cell proliferation by using the chimera decoy of the present invention.
REFERENCES:
patent: 6034234 (2000-03-01), Matsuo et al.
patent: 6262033 (2001-07-01), Morishita et al.
patent: 6774118 (2004-08-01), Dzau et al.
patent: 6821956 (2004-11-01), Dzau et al.
patent: 6841539 (2005-01-01), Mehta et al.
patent: 7060690 (2006-06-01), Klem et al.
patent: 7482158 (2009-01-01), Mathison
patent: 2002/0052333 (2002-05-01), Dzau et al.
patent: 2002/0098162 (2002-07-01), Morishita et al.
patent: 2002/0128217 (2002-09-01), Dzau et al.
patent: 2003/0176376 (2003-09-01), Klem
patent: 2003/0186922 (2003-10-01), Dzau et al.
patent: 2004/0072726 (2004-04-01), Morishita et al.
patent: 2004/0109843 (2004-06-01), Morishita et al.
patent: 2004/0162250 (2004-08-01), Morishita et al.
patent: 2004/0162251 (2004-08-01), Morishita et al.
patent: 2004/0229833 (2004-11-01), Dzau et al.
patent: 2005/0096287 (2005-05-01), Mehta et al.
patent: 2005/0175539 (2005-08-01), Morishita et al.
patent: 2006/0116344 (2006-06-01), Morishita et al.
patent: 2006/0135449 (2006-06-01), Sawa et al.
patent: 2006/0241066 (2006-10-01), Tomita et al.
patent: 2006/0263422 (2006-11-01), Morishita et al.
patent: 2007/0014840 (2007-01-01), Lee et al.
patent: 2008/0207552 (2008-08-01), Sawa et al.
patent: 2009/0105183 (2009-04-01), Morishita et al.
patent: 2002-193813 (2002-07-01), None
patent: 3392143 (2003-01-01), None
patent: 95/11687 (1995-05-01), None
patent: 96/16074 (1996-05-01), None
patent: 96/35430 (1996-11-01), None
patent: 99/60167 (1999-11-01), None
Nakashima et al.,Inhibition of Experimental Abdominal Aortic Aneurysm in the Rat by Use of Decoy Oligodeoxynucleotides Suppressing Activity of Nuclear Factor κB and ets Transcription Factors, Circulation, Jan. 6, 2004, vol. 109, No. 1, pp. 132-138.
Aoki Motokuni
Miyake Takashi
Morishita Ryuichi
Ogihara Toshio
Anges MG Inc.
Marvich Maria
Nixon & Vanderhye P.C.
LandOfFree
Chimera (double) decoy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chimera (double) decoy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimera (double) decoy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4293731